DaebongLS Co Ltd
KOSDAQ:078140
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
DaebongLS Co Ltd
Other Current Liabilities
DaebongLS Co Ltd
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DaebongLS Co Ltd
KOSDAQ:078140
|
Other Current Liabilities
₩5B
|
CAGR 3-Years
36%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
10%
|
|
|
SK IE Technology Co Ltd
KRX:361610
|
Other Current Liabilities
₩24.4B
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
Hansol Chemical Co Ltd
KRX:014680
|
Other Current Liabilities
₩66B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
D
|
Dongjin Semichem Co Ltd
KOSDAQ:005290
|
Other Current Liabilities
₩133.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
22%
|
|
|
S
|
SoulBrain Co Ltd
KOSDAQ:357780
|
Other Current Liabilities
₩64.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Isu Specialty Chemical Co Ltd
KRX:457190
|
Other Current Liabilities
₩11.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaebongLS Co Ltd
Glance View
DaebongLS Co., Ltd. engages in the manufacturing and distributing of raw materials for pharmaceuticals and cosmetics. The company is headquartered in Incheon, Incheon. The company went IPO on 2005-12-23. Co., Ltd. is a Korea-based company engaged in the manufacture of raw materials for pharmaceuticals and cosmetics. The firm operates its business through two main divisions: cosmetic division, which provides aloe vera gels, beta carotens, calamines, diaformers, emulgades and others for conditioners, emulsifiers, emollients, polymers, thickeners and others; pharmaceutical division, which provides almagates, bentonites, calcitriols, erdosteines, fish oil and others for antibiotics, cough products, expectorants and others. In addition, it is involved in the provision of food chemical additives, fish feedstuff and others. The firm distributes its products within domestic market and to overseas markets, including Japan, America and other Southeast Asian countries.
See Also
What is DaebongLS Co Ltd's Other Current Liabilities?
Other Current Liabilities
5B
KRW
Based on the financial report for Dec 31, 2025, DaebongLS Co Ltd's Other Current Liabilities amounts to 5B KRW.
What is DaebongLS Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
10%
Over the last year, the Other Current Liabilities growth was -60%. The average annual Other Current Liabilities growth rates for DaebongLS Co Ltd have been 36% over the past three years , -5% over the past five years , and 10% over the past ten years .
